Idaho Behavioral Health, Inc. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2420 American Legion Blvd, Mountain Home, ID 83647 Phone: 208-580-9525 Fax: 208-580-9527 |
Doctors Clinic Of Elmore County Pllc Family Medicine Medicare: Medicare Enrolled Practice Location: 2000 American Legion Blvd, Mountain Home, ID 83647 Phone: 208-587-1500 Fax: 208-587-3180 |
Michael P Koelsch Md Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 805 N 6th E, Mountain Home, ID 83647 Phone: 208-587-5880 Fax: 208-587-7905 |
St Lukes Rhc - Trinity Mountain Family Medicine Medicare: Medicare Enrolled Practice Location: 465 Mckenna Dr, Mountain Home, ID 83647 Phone: 208-587-9703 |
Desert Sage Health Centers Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 120 Desert Sage Way, Mountain Home, ID 83647 Phone: 208-587-3988 Fax: 208-587-3324 |
North Canyon Mountain Home Clinic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 840 N 4th E, Mountain Home, ID 83647 Phone: 208-934-8829 Fax: 208-934-4874 |
Trinity Mountain Family Practice Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 465 Mckenna Dr, Mountain Home, ID 83647 Phone: 208-587-9703 Fax: 208-580-9812 |
News Archive
In this post in LA Progressive, Georgianne Nienaber, an investigative and political writer, examines the potential effects of reduced PEPFAR funding and highlights the non-denominational Christian ACTS clinic operating in South Africa as an example of a U.S. foreign aid success story.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
Gene therapy could be used as an agent to protect normal tissues, including the esophagus and lung, from damage during a second administration of radiation therapy for non-small cell lung cancer, according to an animal study presented by University of Pittsburgh researchers at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver.
It's been nine years since Harry Folk of Palmer Township had a scare with throat cancer. He is able to talk about his journey, literally, thanks to the treatment he received at St. Luke's. The treatment plan recommended by his cancer team not only removed his cancer, but preserved his voice and ability to swallow without difficulty.
Addressing the nation's continuing poor performance in cancer clinical trial participation, particularly among racial and ethnic minorities and low income groups, will require meaningful public involvement in the design and implementation of clinical trials, according to a landmark report released today.
› Verified 6 days ago